✦ LIBER ✦

O-086 A phase III randomized trial of carboplati/paclitaxel, with or without bexarotene (Targretin®), in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

✍ Scribed by Gatzemeier, U.; Blumenschein, G.; Jotte, R.; von Pawel, J.; Miller, W.; Khuri, E.; Rigas, J.; Mabry, M.; Dziewanowska, Z.; Negro-Vilar, A.

Book ID: 118572633
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 151 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80219-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-082 A randomized phase III trial compa

O-082 A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

✍ Blumenschein, G.; Ludwig, C.; Thomas, G.; Tan, E.; Fanucchi, M.; Santoro, A.; Cr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Phase III trial of cisplatin/gemcitabine

Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer

✍ Pasquale Comella 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 366 KB

A phase III randomized study of carbopla

A phase III randomized study of carboplatin and paclitaxel with or without amifostine in patients with non-small cell lung cancer (NSCLC)

✍ Belani, C.P; Ansari, R.H; Atkins, J.N; Hon, J.K; Modiano, M.R; Budd, T.G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Pemetrexed combined with paclitaxel in p

Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: A phase I-II trial

✍ STATHOPOULOS, G; DIMITROULIS, J; TOUBIS, M; KATIS, C; KARAINDROS, D; STATHOPOULO 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 172 KB

O-086a Randomized phase II/III trial of

O-086a Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C)with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial — E4599

✍ Sandler, A.B.; Gray, R.; Brahmer, J.; Dowlati, A.; Schiller, J.H.; Perry, M.C.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 151 KB

A phase III randomized study of intensiv

A phase III randomized study of intensive cisplatin with or without amifostine in patients with non-small cell lung cancer (NSCLC)

✍ Schiller, J; Von Pawel, J; Gatzemeier, U; Arcenas, A; Tester, W; Kasimis, B; Mac 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 226 KB